Butyric Acid Derivatives Market Regional Analysis:
Asia Pacific industry is likely to hold largest revenue share by 2035. The growth of the market can be attributed majorly to the increasing production of livestock in developing countries such as China, India, Japan, and Korea. It was observed that a significant increase in monogastric livestock, 63 to 75% of total livestock units (LUs), caused the number of livestock units (LUs) in China to triple within 30 years. Moreover, the rising per capita income, growing population, high consumption of poultry products, growing animal husbandry activities, and rising awareness towards the adoption of a healthy lifestyle are factors expected to drive the global butyric acid derivatives market in the region during the forecast period.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of butyric acid derivatives is estimated at USD 1.11 Billion.
The global butyric acid derivatives market size was around USD 1.05 Billion in 2025 and is likely to expand at a CAGR of more than 6.2%, surpassing USD 1.92 Billion revenue by 2035.
Asia Pacific’s butyric acid derivatives market holds the largest share by 2035, driven by livestock production increase and growing demand for poultry and animal health.
Key players in the market include Nutreco N.V., The Eastman Chemical Company, Koninklijke DSM N.V., Kemin Industries Inc., Metabolic Explorer S.A., Bioscreen Technologies S.r.l., Innovad Ad NV/SA, Palital BV, Alfa Aesar (China) Co. Ltd., OQ Chemicals GmbH, KUNSHAN ODOWELL CO. LTD.
